supports research. However, they do not have their own medical school or innovation district. Dr Julie Ann Freischlag, CEO of AHWFB, chief academic officer of Atrium Health and dean of the WFU School of Medicine said this about the merger's impact on the medical school “We’re really excited that the way this is set up. We’ll be a part of a bigger group, so I think if anything, people will know more who we are, and we’ll be able to touch more people and tell them about the research and education — the wonderful things we do.” Freischlag stated completing clinical trials and finding new treatment approaches will be easier with a larger patient population. The deal faced a number of approval hurdles. The North Carolina Attorney General stated he would not oppose the deal, the Federal Trade Commission reviewed the merger, the deal was subject to Illinois and Wisconsin approval since Advocate Aurora is based in both states. The deal was temporarily blocked by Illinois health board and then decided to postpone the vote. During a special meeting on November 14, 2022 the board voted 6-0 to approve the deal. The merger was completed on December 2, 2022. Controversy On June 9, 2016, it was reported that the U.S. Justice Department and the N.C. Attorney General's office filed a federal antitrust lawsuit against Carolinas HealthCare System, alleging the chain illegally reduces competition in the local health care market. Atrium Health settled the lawsuit with the Antitrust Division of the U.S. Department of Justice on November 15, 2018. The settlement included injunctive terms restricting Atrium's ability to add provisions to its contracts that would be considered anticompetitive. On July 3, 2017, it was reported that Carolina's Healthcare System (CHS) had agreed to pay a $6.5 million False Claims Act settlement to settle charges over its billing practices brought by a whistle blower, U.S. Attorney Jill Rose said Friday. Prosecutors contended the Charlotte-based hospital system had been improperly “up-coding” claims for urine drug tests in order to receive much higher payments than CHS would have if billed properly. CHS contended that two separate consultants had reviewed its practices and had confirmed its coding selection amid “complex and constantly changing billing guidelines.” After two years into the process, CHS said it was in the system's best interest to resolve the charges. See also List of public hospitals in the United States External